FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · MHRA (UK MEDICINES REGULATOR) · 27 October 2026

Access, new active substance and biosimilar work sharing initiatives

Synopsis

The Biosimilar Work Sharing Initiative (BSWSI) builds on this success. The timelines for this will be dependent on the milestones for the review agreed by the participating regulators.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at MHRA (UK medicines regulator) ↗

More in New medicines and drug discovery